PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics announced the appointment of Anthony Tolcher, MD, to its Scientific Advisory Board (SAB). Dr. Tolcher will provide strategic counsel on the development of novel Centyrin therapeutic candidates for oncology indications. “We are excited and pleased to have Dr. Tolcher, a well-known leader in translational oncology clinical research join Aro’s SAB,” said Sue Dillon, PhD, Co-founder and Chief Executive Officer of Aro. “As we progress our Centyrin p http://www.businesswire.com/news/home/20190501005141/en/Aro-Biotherapeutics-Appoints-Anthony-Tolcher-MD-Scientific/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.